The Role of Obsessive-Compulsive Factors in the Treatment of Binge-Eating Disorders: A Post-Hoc Analysis of a Double-Blind, Placebo-Controlled Trial of Dasotraline

被引：0
|
作者：
Loebel, Antony [1 ]
Goldman, Robert [1 ]
Citrome, Leslie [1 ]
Siu, Cynthia [1 ]
Tsai, Joyce [1 ]
Kent, Justine [1 ]
机构：
[1] Sunovion Pharmaceut Inc, Ft Lee, NJ USA
来源：
NEUROPSYCHOPHARMACOLOGY | 2019年 / 44卷 / SUPPL 1期
关键词：
Binge Eating Disorder; Obsessive Compulsive Disorder; Dasotraline;
D O I：
暂无
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
M68
引用
收藏
页码：112 / 113
页数：2
相关论文
共 50 条
  • [1] Fluvoxamine in the treatment of binge-eating disorder: A multicenter placebo-controlled, double-blind trial
    Hudson, JI
    McElroy, SL
    Raymond, NC
    Crow, S
    Keck, PE
    Carter, WP
    Mitchell, JE
    Strakowski, SM
    Pope, HG
    Coleman, BS
    Jonas, JM
    AMERICAN JOURNAL OF PSYCHIATRY, 1998, 155 (12): : 1756 - 1762
  • [2] A double-blind, placebo-controlled trial of clonazepam in obsessive-compulsive disorder
    Hollander, E
    Kaplan, A
    Stahl, SM
    WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY, 2003, 4 (01): : 30 - 34
  • [3] Treatment of obsessive-compulsive disorder with fluvoxamine: A multicentre, double-blind, placebo-controlled trial
    Goodman, WK
    Kozak, MJ
    Liebowitz, M
    White, KL
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 1996, 11 (01) : 21 - 29
  • [4] Double-blind, placebo-controlled trial of topiramate augmentation in the treatment of obsessive-compulsive disorder
    Berlin, Heather A.
    Koran, Lorrin M.
    Jenike, Michael A.
    Shapira, Nathan A.
    Chaplin, William
    Pallanti, Stefano
    Hollander, Eric
    BIOLOGICAL PSYCHIATRY, 2008, 63 (07) : 170S - 170S
  • [5] A double-blind, placebo-controlled study of vortioxetine in the treatment of binge-eating disorder
    Grant, Jon E.
    Valle, Stephanie
    Cavic, Elizabeth
    Redden, Sarah A.
    Chamberlain, Samuel R.
    INTERNATIONAL JOURNAL OF EATING DISORDERS, 2019, 52 (07) : 786 - 794
  • [6] Naltrexone/bupropion for binge-eating disorder: A randomized, double-blind, placebo-controlled trial
    Grilo, Carlos M.
    Lydecker, Janet A.
    Jastreboff, Ania M.
    Pittman, Brian
    Mckee, Sherry A.
    OBESITY, 2023, 31 (11) : 2762 - 2773
  • [7] Combination of clomipramine and nortriptyline in the treatment of obsessive-compulsive disorder: a double-blind, placebo-controlled trial
    Noorbala, AA
    Hosseini, SH
    Mohammadi, MR
    Akhondzadeh, S
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 1998, 23 (02) : 155 - 159
  • [8] A randomized, double-blind, placebo-controlled study of sibutramine in the treatment of binge-eating disorder
    Appolinario, JC
    Bacaltchuk, J
    Sichieri, R
    Claudino, AM
    Godoy-Matos, A
    Morgan, C
    Zanella, MT
    Coutinho, W
    ARCHIVES OF GENERAL PSYCHIATRY, 2003, 60 (11) : 1109 - 1116
  • [9] Bupropion for Overweight Women With Binge-Eating Disorder: A Randomized, Double-Blind, Placebo-Controlled Trial
    White, Marney A.
    Grilo, Carlos M.
    JOURNAL OF CLINICAL PSYCHIATRY, 2013, 74 (04) : 400 - 406
  • [10] Tolcapone in obsessive-compulsive disorder: a randomized double-blind placebo-controlled crossover trial
    Grant, Jon E.
    Hook, Roxanne
    Valle, Stephanie
    Chesivoir, Eve
    Chamberlain, Samuel R.
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2021, 36 (05) : 225 - 229
12345